Mesenchymal Stem Cells from iPS Cells Facilitate Periodontal Regeneration

  title={Mesenchymal Stem Cells from iPS Cells Facilitate Periodontal Regeneration},
  author={Kim Hynes and Danijela Menicanin and J Y Han and Victor Fernandes Marino and Krzysztof Marek Mrozik and Stan Gronthos and Peter Mark Bartold},
  journal={Journal of Dental Research},
  pages={833 - 839}
Mesenchymal stem cells (MSC) have been considered as a potential therapy for the treatment of periodontal defects arising from periodontitis. However, issues surrounding their accessibility and proliferation in culture significantly limit their ability to be used as a mainstream treatment approach. It is therefore important that alternative, easily accessible, and safe populations of stem cells be identified. Controlled induction of induced pluripotent stem cells (iPSC) into MSC-like cells is… 

Figures from this paper

Human Gingival Integration-Free iPSCs; a Source for MSC-Like Cell

It is demonstrated that human gingival integration-free iPSCs, readily accessible stem cells generated using episomal plasmid vectors, are a promising source of MSLCs, which can be used in tissue regeneration.

Dental applications of induced pluripotent stem cells and their derivatives

Generation and Applications of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells

Methods that induce and characterize MSCs derived from induced pluripotent stem cells (iPSCs) are reviewed and MSC applications to disease modeling, pathogenic mechanisms, and drug discovery are introduced.

Deriving Osteogenic Cells from Induced Pluripotent Stem Cells for Bone Tissue Engineering.

A perspective on the comparisons of osteogenic potentials of iPSC-derived osteogenic cells produced by different protocols, including iPSCs from different somatic origins, and iPSS-derived MSC-like cells and bone marrow stem cells is provided.

Differentiation of iPSC to Mesenchymal Stem-Like Cells and Their Characterization.

The present chapter describes a method for generating MSC-like cells from induced pluripotent stem cells (iPSC), with equivalent growth and functional properties to parental MSC populations.

Generation, Characterization, and Multilineage Potency of Mesenchymal-Like Progenitors Derived from Equine Induced Pluripotent Stem Cells.

A protocol for the derivation of MSC-like progenitor populations from equine iPS cells is demonstrated and the multilineage differentiation potential of iPSC-MSCs is assessed.

Potential of iPSC-Derived Mesenchymal Stromal Cells for Treating Periodontal Disease

It is demonstrated that miPSC-MSC derived from iPSC have the capacity to control acute and chronic inflammatory responses associated with the destruction of periodontal tissue and present a promising novel source of stromal cells which could be used in the treatment ofperiodontal disease and other inflammatory systemic diseases such as rheumatoid arthritis.

Growth/differentiation factor-5 promotes in vitro/vivo periodontal specific differentiation of induced pluripotent stem cell-derived mesenchymal stem cells

iPSC-MSCs demonstrate high periodontal specific differentiation potential in response to rhGDF-5 both in vitro and in vivo, and the delivery of iPSC -MSCs and rhG DF-5 with HA hydrogel may have beneficial effects in regenerativeperiodontal therapy.

Pluripotent-derived Mesenchymal Stem/stromal Cells: an Overview of the Derivation Protocol Efficacies and the Differences Among the Derived Cells

The present review addresses the developmental basis behind some of these derivation protocols of MSC-like cells by exposing the differences among them and discussing the functional properties of PSC-MSCs, shedding light on elements that may help determine standard characterizations and criteria to evaluate and define these cells.

Generation, Characterization, and Multilineage Potency of Mesenchymal-Like Progenitors Derived from Equine iPS Cells

A protocol for the derivation of MSC-like progenitor populations from equine iPS cells is demonstrated and the multilineage differentiation potential of iPSC-MSCs is assessed.



Application of induced pluripotent stem (iPS) cells in periodontal tissue regeneration

The results showed the commitment role that EMD contributes in mesenchymal progenitors to early cells in the osteogenic lineage, by promoting the formation of new cementum, alveolar bone, and normal periodontal ligament.

Functional Mesenchymal Stem Cells Derived From Human Induced Pluripotent Stem Cells Attenuate Limb Ischemia in Mice

Functional MSCs can be clonally generated, beginning at a single-cell level, from human iPSCs and can be prepared as an “off-the-shelf” format for the treatment of tissue ischemia.

Small Molecule Mesengenic Induction of Human Induced Pluripotent Stem Cells to Generate Mesenchymal Stem/Stromal Cells

It is concluded that treatment with SB431542 in two‐dimensional cultures followed by culture‐induced epithelial‐to‐mesenchymal transition leads to rapid and uniform MSC conversion of human pluripotent cells without the need for embryoid body formation or feeder cell coculture, providing a robust, clinically applicable, and efficient system for generating MSCs from human iPSCs.

Efficient differentiation of human iPSC‐derived mesenchymal stem cells to chondroprogenitor cells

The data indicate the derivation of a mesenchymal stem cell population from human iPSCs is necessary to limit culture heterogeneity as well as chondrocyte maturation in the differentiated progeny, and represents a first step toward identifying the most suitable iPSC progeny for developing cell‐based approaches to repair joint cartilage damage.

Clinical applications of mesenchymal stem cells

In the clinical setting, MSCs are being explored in trials of various conditions, including orthopedic injuries, graft versus host disease following bone marrow transplantation, cardiovascular diseases, autoimmune diseases, and liver diseases.

Derivation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Cultured on Synthetic Substrates

It is demonstrated that hiPSCs cultured in a xeno‐free system have the capability to differentiate into functional MSCs with the ability to form bone in vivo.

Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery.

It is shown, for the first time, that IPS-derived MSCs display remarkable inhibition of NK-cell proliferation and cytolytic function in a similar way to ES-MSCs, which could represent an attractive alternative source of immunoregulatory cells.

One-Step Derivation of Mesenchymal Stem Cell (MSC)-Like Cells from Human Pluripotent Stem Cells on a Fibrillar Collagen Coating

It is demonstrated that bioimimetic, fibrillar, type I collagen coatings applied to cell culture plates can be used to guide a rapid, efficient derivation of MSC-like cells from both human ES and iPS cells.

Efficient Derivation and Concise Gene Expression Profiling of Human Embryonic Stem Cell-Derived Mesenchymal Progenitors (EMPs)

A simple and efficient method is reported of generating hESC-derived mesenchymal progenitors (EMPs) and transcriptome profiling using a concise, custom-designed, oligomnucleotide gene expression microarray and it is found that the transcriptome of EMPs is more similar to BMMSCs than hESCs.